PDF Archive

Easily share your PDF documents with your contacts, on the Web and Social Networks.

Share a file Manage my documents Convert Recover PDF Search Help Contact



Hepatitis C Market PDF .pdf



Original filename: Hepatitis C Market - PDF.pdf
Title: Asia Medical Tourism Analysis (2008 – 2013)
Author: Publisher: Renub Research

This PDF 1.5 document has been generated by Microsoft® Office Word 2007, and has been sent on pdf-archive.com on 17/11/2015 at 06:58, from IP address 182.69.x.x. The current document download page has been viewed 472 times.
File size: 579 KB (12 pages).
Privacy: public file




Download original PDF file









Document preview


Renub Research
www.renub.com
Hepatitis C Market & Forecast, Hepatitis C Pipeline
Drugs Sales & Forecast, Clinical Trials - Global

Published: August, 2015
Copyright © 2015 Renub Research – All Rights Reserved

Market for Hepatitis C drugs has grown with a phenomenal rate of more than US$ 13 Billion, in
the year 2014 compared to 2013. In the last two years a couple of new drugs have been
introduced in the market which has become a huge success and they have captured maximum
market share of the Hepatitis C market. Gilead currently dominates the multi-billion dollar
Hepatitis C market, but AbbVie has been trying to increase its market share since U.S.
regulators approved the marketing of its Viekira Pak. Drug makers are already focusing on
introducing new drugs in the market as several drugs are standing in the pipeline. Hepatitis C
Drugs is anticipated to be a rosy market for future period.
This is 3rd edition report on Hepatitis C Drugs Industry by Renub Research. Report titled
“Hepatitis C Market & Forecast, HCV Drugs Clinical Trials, Hepatitis C Pipeline Drugs Sales
& Forecast - Global” provides a comprehensive assessment of the fast-evolving, high-growth of
Hepatitis sector. This 87 page report with 18 Figures and 1 Table studies the Hepatitis C Drug
Market Landscape.
1. Hepatitis C Drugs Market & Forecast (Chapter 2)
2. Hepatitis C Approved Drugs Sales & Forecast (Chapter 3)
3. Hepatitis C – Pipeline Drugs Sales & Forecast (Chapter 4)
4. Hepatitis C Deals & Acquisitions (Chapter 5)
5. Hepatitis C – Company Wise Clinical Trial Analysis (Chapter 6)

Hepatitis C – Approved Drugs Sales & Forecast (To 2020) (Chapter No. 3)
1. Pegasys
2. Pegintron
3. Incivek
4. Victrelis
5. Olysio
6. Sovaldi/Harvoni
7. HCV Franchise
8. Viekira Pak

Hepatitis C – Pipeline Drugs Sales Forecast (To 2020) (Chapter No. 4)
1. Drug A (Merck & Co. Inc.)
2. Drug B (Merck & Co. Inc.)
3. Drug C (Bristol-Myers Squibb)

Hepatitis C – Company Wise Clinical Trial Analysis (Chapter No.5)
1. AbbVie
2. Bristol-Myers Squibb (BMS)
3. Gilead Sciences
4. Merck & Co. Inc.
5. Tibotec/Janssen Therapeutics

Data Sources
This report is built using data and information sourced from proprietary databases, primary and
secondary research and in-house analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephone interviews with industry experts.
Secondary sources information and data has been collected from various printable and nonprintable sources like search engines, News websites, Government Websites, Trade Journals,
White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books,
Industry Portals, Industry Associations and access to more than 500 paid databases.

© Renub Research

Page 3 of 12

About Us
Renub Research

is a leading Market Research and Information Analysis Company with

centers at Noida India and Roswell USA. We have long-term experience especially in
international Business-to-Business Researches, Surveys, Business and Consulting. Throughout
the years we have acquired expertise in most market sectors, including Information Technology
(IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking,
Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer
Goods, Logistics, Governmental, Social, and Others.
Our core team is comprised of an experienced people holding graduate, post graduate and
Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information
Technology, Environmental Science and many more. Our research help make the business
decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We
support many blue chip companies by providing them findings and perspectives across a wide
range of markets. Our research reports offer a blend of information insight, analysis and
forecasting that is essential in today’s ultra-competitive markets.

For more information on us or to view any of our sample work you can mail
us at info@renub.com

© Renub Research

Page 4 of 12

Published
By

Renub Research
1st Floor,
C – 86, Sector - 10
Noida – 201301
Phone: +91-120-421-9822, 254-5750 (India)
+1-678-302-0700 (USA)
Fax : +91-120-424-9780
Email: info@renub.com
www.renub.com

© Hepatitis C Market & Forecast, HCV Drugs Clinical Trials, Hepatitis C Pipeline Drugs Sales
& Forecast - Global
Renub Research, 2015
Edition 3.0
All rights reserved. This publication is protected
by copyright. No part of it may be reproduced, stored
in a retrieval system or transmitted, in any form or by
any means, electronic mechanical, photocopying,
recording or otherwise without the prior written
permission of the publishers

© Renub Research

Page 5 of 12

Table of Contents
1.

Executive Summary

2.

Hepatitis C Drugs – Market & Forecast

3.

Hepatitis C – Approved Drugs Sales & Forecast

4.

3.1

Pegasys Sales & Forecast

3.2

Pegintron Sales & Forecast

3.3

Incivek Sales

3.4

Victrelis Sales & Forecast

3.5

Olysio Sales & Forecast

3.6

Sovaldi / Harvoni Sales & Forecast

3.7

HCV Franchise Sales & Forecast

3.8

Viekira Pak Sales & Forecast

Hepatitis C - Pipeline Drugs Sales Forecast
4.1

Drug A of (Merck & Co. Inc.)

4.2

Drug B of (Merck & Co. Inc.)

4.3

Drug C of (Bristol-Myers Squibb)

5.

Hepatitis C – Deals & Acquisitions

6.

Hepatitis C – Company Wise Clinical Trials Analysis
6.1

AbbVie – Clinical Trials

6.1.1

Phase III

6.1.2

Phase II

6.1.3

Phase I

6.2

Bristol-Myers Squibb (BMS) – Clinical Trials

6.2.1

Phase III

© Renub Research

Page 6 of 12

6.2.2
6.3

Gilead Sciences – Clinical Trials

6.3.1
6.4

Phase II

Phase II

Merck & Co. Inc. – Clinical Trials

6.4.1

Phase IV

6.4.2

Phase III

6.4.3

Phase II

6.4.4

Phase I

6.5

Tibotec / Janssen Therapeutics – Clinical Trials

6.5.1

Phase IV

6.5.2

Phase III

6.5.3

Phase II

6.5.4

Phase I

© Renub Research

Page 7 of 12

List of Figures:
Figure 2-1: Global – Hepatitis C Drug Market (Million US$), 2010 – 2014
Figure 2-2: Global – Forecast for Hepatitis C Drug Market (Million US$), 2015 – 2020
Figure 3-1: Global – Pegasys Sales (Million US$), 2005 – 2014
Figure 3-2: Global – Forecast for Pegasys Sales (Million US$), 2015 – 2020
Figure 3-3: Global – Pegintron Sales (Million US$), 2010 – 2014
Figure 3-4: Global – Forecast for Pegintron Sales (Million US$), 2015 – 2020
Figure 3-5: Global – Incivek Sales (Million US$), 2011 – 2014
Figure 3-6: Global – Victrelis Sales & Forecast (Million US$), 2011 – 2015
Figure 3-7: Global – Olysio Sales (Million US$), 2013 – 2014
Figure 3-8: Global – Forecast for Olysio Sales (Million US$), 2015 – 2020
Figure 3-9: Global – Sovaldi/Harvoni Sales (Million US$), 2013 – 2014
Figure 3-10: Global – Forecast for Sovaldi/Harvoni Sales (Million US$), 2015 – 2020
Figure 3-11: Global – HCV Franchise Sales & Forecast (Million US$), 2014 – 2020
Figure 3-12: Hepatitis C Drugs – Viekira Pak, Sovaldi & Harvoni Initial Prescription (Number), 2013, 2014
Figure 3-13: Global – Viekira Pak Sales & Forecast (Million US$), 2014 – 2020

Figure 4-1: Global – Forecast for Vaniprevir (MK-7009) Sales (Million US$), 2015 – 2020
Figure 4-2: Global – Forecast for Grazoprevir/Elbasvir (MK-5172 + MK-8742) Sales (Million US$), 2016 –
2020
Figure 4-3: Global – Forecast for PEG-Interferon Lambda Sales (Million US$), 2015 – 2020

© Renub Research

Page 8 of 12

List of Tables:
Table 5-1: Hepatitis C – Deals & Acquisitions in the anti-HCV Drug Space, 2004 – 2012

© Renub Research

Page 9 of 12


Related documents


hepatitis c market pdf
global alzheimer s disease drugs market
osteoporosis market pdf
pd 1 pd l1 inhibitors
clinical trails management systems market
contract research organizations market


Related keywords